Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2025-12-24 @ 11:24 PM
NCT ID:
NCT05813756
Brief Summary:
The primary objective of the study is to evaluate the effectiveness of a post-diagnostic psychoeducational intervention in increasing the sense of self-efficacy of adults diagnosed with Autism Spectrum Disorder-Without associated Intellectual Disability
Detailed Description:
Secondary objectives
The other objectives of this study are :
1. To evaluate the effectiveness of the intervention on self-esteem ;
2. To evaluate the effectiveness of the intervention on anxiety-depressive symptomatology ;
3. To evaluate the effectiveness of the intervention on the acceptance of the diagnosis ;
4. To evaluate the acceptance of the intervention.
Conduct of research The study will be offered to individuals diagnosed with autism spectrum disorder without associated intellectual developmental disabilities in adulthood.
After signing the consent form and verifying the eligibility criteria, participants will be randomized into the waiting list group or the intervention group.
In the intervention group : the participant will receive 10 one-hour individual sessions, bi-monthly, with an assessment at midterm (T1 : T0+\~2.5 months), at the end of the intervention (T2 : T0 +\~5 months) and 3 months after the intervention (T3 : T0 +\~8 months).
In the waiting list group : the participant will receive the intervention at the exit of the research protocol (after T3).
At conclusion and at each visit, participants will complete questionnaires and scales defined in the protocol.
Study:
NCT05813756
Study Brief:
Protocol Section:
NCT05813756